Kezar Life Sciences Inc (KZR) stock forecast · $53.9M cap
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
This KZR forecast page states what the cached financials imply — not a price target and not a guarantee. Kezar Life Sciences Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
The near-term path: Revenue was down 100.0% from 2023-12-31 to 2024-12-31. A forecast that ignores that change is just a story.
KZR currently screens at market cap $53.9M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next KZR 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the KZR stock page.
Not investment advice.